ISRCTN17332543进行中（未招募）未知
Circulating tumour cells as biomarkers to predict prostate cancer metastasis for treatment stratification of localised cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 490
研究概览
简要总结
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37353740/ (added 26/06/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. High/High intermediate risk non-metastatic risk localised PCa based on the EAU stratification system
- •2. Scheduled for robot-assisted RP
- •3. Informed consent
排除标准
- •1. With other co-occurring cancers
- •2. Neo-adjuvant ADT
- •3. Adjuvant ADT
研究者
相似试验
已完成
不适用
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerProstate CancerNCT05533515Queen Mary University of London330
已完成
不适用
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsNasopharyngeal NeoplasmsNCT02505139Sun Yat-sen University166
已完成
Unknown
INTENT_Circulating tumor cells as biomarkers for recurrence risk in thermoablatioC22.0Liver cell carcinomaDRKS00016808Klinikum der Universität München, Campus Großhadern100
已完成
不适用
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal CancerClear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial CellsPrognostic BiomarkersPredictive BiomarkersNCT02499458Lawson Health Research Institute44
终止
不适用
Prognostic Value of CTC in HNSCC PatientsRecurrenceMetastasisDeathNCT01884129Chang Gung Memorial Hospital53